Literature DB >> 1802502

Eosinophilic fasciitis presenting with a reactive hepatitis.

A E Loeliger1, H R van den Brink, R H Derksen, J W Bijlsma.   

Abstract

We report a patient with eosinophilic fasciitis, reactive hepatitis and splenomegaly. Administration of prednisone resulted in normalization of liver enzymes and spleen-size and an improvement of his clinical condition. These uncommon manifestations are only part of the broadening clinical spectrum, which is discussed briefly.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1802502     DOI: 10.1007/BF02206669

Source DB:  PubMed          Journal:  Clin Rheumatol        ISSN: 0770-3198            Impact factor:   2.980


  23 in total

1.  Interim guidance on the eosinophilia-myalgia syndrome.

Authors:  E M Kilbourne; L A Swygert; R M Philen; R K Sun; S B Auerbach; L Miller; D E Nelson; H Falk
Journal:  Ann Intern Med       Date:  1990-01-15       Impact factor: 25.391

2.  Eosinophilic fasciitis.

Authors:  P J Maddison
Journal:  Br J Rheumatol       Date:  1990-04

3.  Antibody-mediated aplastic anemia and diffuse fasciitis.

Authors:  R Hoffman; N Dainiak; L Sibrack; J S Pober; J A Waldron
Journal:  N Engl J Med       Date:  1979-03-29       Impact factor: 91.245

Review 4.  Eosinophilic fasciitis: extracutaneous manifestations and associations.

Authors:  J A Doyle
Journal:  Cutis       Date:  1984-09

5.  Diffuse fasciitis with eosinophilia. A clinicopathologic study.

Authors:  H M Moutsopoulos; B L Webber; N A Pavlidis; G Fostiropoulos; D Goules; L E Shulman
Journal:  Am J Med       Date:  1980-05       Impact factor: 4.965

6.  Eosinophilic fasciitis, reactive hepatitis, and splenomegaly.

Authors:  M B Jacobs
Journal:  Arch Intern Med       Date:  1985-01

7.  Circulating immune complexes in eosinophilic fasciitis.

Authors:  J R Seibold; G P Rodnan; T A Medsger; A Winkelstein
Journal:  Arthritis Rheum       Date:  1982-10

8.  Frequency, levels, and significance of blood eosinophilia in systemic sclerosis, localized scleroderma, and eosinophilic fasciitis.

Authors:  V Falanga; T A Medsger
Journal:  J Am Acad Dermatol       Date:  1987-10       Impact factor: 11.527

9.  Eosinophilic fasciitis: report of a case with features of connective tissue diseases.

Authors:  N Kaplinsky; M Revach; W A Katz
Journal:  J Rheumatol       Date:  1980 Jul-Aug       Impact factor: 4.666

10.  Development of diffuse fasciitis with eosinophilia during L-tryptophan treatment: demonstration of elevated type I collagen gene expression in affected tissues. A clinicopathologic study of four patients.

Authors:  J Varga; J Peltonen; J Uitto; S Jimenez
Journal:  Ann Intern Med       Date:  1990-03-01       Impact factor: 25.391

View more
  5 in total

1.  Unusual presentation of eosinophilic fasciitis (EF) with a raised ALT.

Authors:  Thomas Batty; Shuja Majeed; Christina Wlodek; Harsha Gunawardena
Journal:  BMJ Case Rep       Date:  2018-12-22

2.  Eosinophilic hepatitis: a new feature of the clinical spectrum of the eosinophilia-myalgia syndrome.

Authors:  P Martinez-Osuna; C G Espinoza; M L Cuellar; G E Cabrera; L H Silveira; L R Espinoza
Journal:  Clin Rheumatol       Date:  1994-09       Impact factor: 2.980

3.  Eosinophilic fasciitis (Shulman's disease): review and comparative evaluation of seven patients.

Authors:  Joana Urzal; Miriam Cimbron; Teresa Mendonça; Fátima Farinha
Journal:  Reumatologia       Date:  2019-04-29

Review 4.  Eosinophilic fasciitis: report of two cases and a systematic review of the literature dealing with clinical variables that predict outcome.

Authors:  Yukie Endo; Atsushi Tamura; Youichiro Matsushima; Tomoko Iwasaki; Michiko Hasegawa; Yayoi Nagai; Osamu Ishikawa
Journal:  Clin Rheumatol       Date:  2007-03-08       Impact factor: 3.650

5.  A Histologically Proven Case of Autoimmune Hepatitis with Eosinophilic Fasciitis.

Authors:  Shohei Asada; Akitoshi Douhara; Koji Murata; Koji Yanase; Masahiro Tsutsumi; Hitoshi Yoshiji
Journal:  Intern Med       Date:  2018-10-17       Impact factor: 1.271

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.